Diagnostics company bioMerieux (PARIS:BIM) has received 510(k) clearance from the U.S. Food and Drug Administration for a test to detect and screen for methicillin-resistant staphylococcus, more ...
On Monday, the U.S. Food and Drug Administration approved a new test for methicillin-resistant Staphylococcus aureus detection manufactured by Cepheid. Cepheid’s Xpert MRSA NxG test delivers ...
The FDA has approved the first rapid blood test for methicillin-resistant Staphylococcus aureus (MRSA). It is the two-hour BD GeneOhm StaphSR Assay, which identified 100% of the MRSA-positive ...
The increasing prevalence of antibiotic resistance, when infectious bacteria evolve to evade drugs designed to control them, is a pressing public health concern. Each year two million Americans ...
MRSA screening is a low risk procedure used to determine whether you have MRSA on your skin or a MRSA infection. Antibiotic treatments are available if you test positive. MRSA is a type of ...
Co announces it received clearance from the FDA to market its Xpert M.R.S.A test, which runs on the GeneXpert System, for the rapid detection of Methicillin-resistant Staphylococcus aureus. "Currently ...
MRSA symptoms vary depending on the infection site, commonly appearing on the skin as bumps or lesions, but can also affect the lungs, bones, blood, and heart. MRSA skin infections can resemble other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback